Update on novel monoclonal antibodies and immunoconjugates for the treatment of lymphoproliferative disorders. - Wikidata - wikimedia - TriplyDB

Update on novel monoclonal antibodies and immunoconjugates for the treatment of lymphoproliferative disorders.

Update on novel monoclonal antibodies and immunoconjugates for the treatment of lymphoproliferative disorders.

http://www.wikidata.org/entity/Q37913356

about

Recent advances in acute myeloid leukemia stem cell biology 7th cancer scientific forum of theCancéropôle Lyon Auvergne Rhône-Alpes: March 20-21, 2012, Lyon, France.

P2860

Q38003359-623308FF-C57D-4A37-B39B-1442F880E831 Q42333450-51D5DEDE-0F9D-468A-95B8-41BC8797C418

P2860

Update on novel monoclonal antibodies and immunoconjugates for the treatment of lymphoproliferative disorders.

http://www.wikidata.org/entity/Q37913356

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Update on novel monoclonal ant ...... lymphoproliferative disorders.

@en

Update on novel monoclonal ant ...... lymphoproliferative disorders.

@nl

type

label

Update on novel monoclonal ant ...... lymphoproliferative disorders.

@en

Update on novel monoclonal ant ...... lymphoproliferative disorders.

@nl

prefLabel

Update on novel monoclonal ant ...... lymphoproliferative disorders.

@en

Update on novel monoclonal ant ...... lymphoproliferative disorders.

@nl

P1433

Q37913356-FE323F39-29AB-4F6F-9F06-8F8F76B354E4

P1476

Q37913356-F3700515-97EB-47C9-82E6-B1BA50968F50

P2093

Q37913356-5A172005-6A06-4948-9B15-6B3A297178B3

Q37913356-7110EC93-CB89-46E4-8D0B-F30A75030CFD

P2860

Q37913356-00976047-9298-4529-A2C0-E160E227C88A

Q37913356-03939E01-250D-4056-8C7D-D37DC2D1E54B

Q37913356-09D2849A-8BCB-43A9-957C-9A37A5741BD4

Q37913356-0AFA7512-D88A-4CB1-9DB0-CCD9BA202E4F

Q37913356-0F6E992F-8504-4C66-9E27-1F561BF65A5B

Q37913356-115BF9B1-EC33-4A7B-A352-591322EB97C8

Q37913356-1223C619-6BB4-4154-81CA-8293CFBD16F1

Q37913356-266DDC70-0E75-4EC0-A768-23DC21E9D48C

Q37913356-2A85C08E-BACB-4E7C-97A4-C730538BB35D

Q37913356-2B53121A-FD3C-4FF6-A2D0-2569BA1B3F0C

P304

Q37913356-A684B0E8-22E7-4D53-B786-598ECF09D1C0

P31

Q37913356-21FC0FBC-E55C-4D63-BB08-EAF8CAA9904D

P356

Q37913356-73FFC029-E6C0-4132-BFF7-42B5BD4A28F7

P407

Q37913356-B84F07F7-C546-4D72-B48D-C587EA5C9FF6

P433

Q37913356-382A558F-D6BB-44AD-ABCC-39516B10A52A

P478

Q37913356-F7E7D40F-C5E6-44F6-B3EF-D86DC87E7F7A

P577

Q37913356-D19395CC-6BF4-40A8-BB81-E640DD34C09D

P698

Q37913356-ADA6449F-6034-4751-BC81-0EFA4B18607B

P356

P1433

Future Oncology

P1476

Update on novel monoclonal ant ...... lymphoproliferative disorders.

@en

P2093

Lyudmyla Derby

http://www.w3.org/2001/XMLSchema#string

Myron S Czuczman

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease

HGS-ETR1, a fully human TRAIL-receptor 1 monoclonal antibody, induces cell death in multiple tumour types in vitro and in vivo

Continuous cultures of fused cells secreting antibody of predefined specificity

Structure of the Fab fragment of therapeutic antibody Ofatumumab provides insights into the recognition mechanism with CD20

Ocrelizumab: a step forward in the evolution of B-cell therapy

Safety and efficacy of ofatumumab, a fully human monoclonal anti-CD20 antibody, in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: a phase 1-2 study

Phase 1/2 study of lumiliximab combined with fludarabine, cyclophosphamide, and rituximab in patients with relapsed or refractory chronic lymphocytic leukemia

Both extracellular immunoglobin-like domains of CD80 contain residues critical for binding T cell surface receptors CTLA-4 and CD28

Tumor regression in cancer patients by very low doses of a T cell-engaging antibody

The biology of CD20 and its potential as a target for mAb therapy

P304

963-979

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FON.11.79

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21823892

http://www.w3.org/2001/XMLSchema#string